Peng XL, Tian JY, Cao Q. Value of detection of serum ischemia-modified albumin in diagnosis of ischemic colitis.
Shijie Huaren Xiaohua Zazhi 2016;
24:4004-4007. [DOI:
10.11569/wcjd.v24.i28.4004]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM
To assess the diagnostic value of serum ischemia-modified albumin for ischemic colitis in order to find a simple, economical and sensitive diagnostic method for this disease.
METHODS
From July 2013 to April 2016, 60 cases of ischemic colitis were diagnosed by colonoscopy. Fifty-eight patients who were hospitalized during the same period but had a normal colonoscopy were included as a control group. After admission, blood serum ischemia modified albumin levels were measured. Statistical analysis was then used to analyze the value of serum ischemia modified albumin in early diagnosis of ischemic colitis.
RESULTS
In 60 patients with ischemic colitis confirmed by colonoscopy, the average level of serum ischemia modified albumin was 12.75 mg/L ± 3.51 mg/L. In 58 patients in the control group, the average level of serum ischemia modified albumin was 0.14 mg/L ± 0.02 mg/L. There was a significant difference in serum ischemia modified albumin level between the two groups (P < 0.05).
CONCLUSION
Serum ischemia modified albumin is significantly higher in patients with ischemic colitis than in controls, suggesting that early detection of ischemia modified albumin can be helpful for the early diagnosis of ischemic colitis.
Collapse